Intellectual Property Rights and the Life Science Industries: Past, Present and Future
This book is a highly readable and entertaining account of the co-evolution of the patent system and the life science industries since the mid-19th century. The pharmaceutical industries have their origins in advances in synthetic chemistry and in natural products research. Both approaches to drug discovery and business have shaped patent law, as have the lobbying activities of the firms involved and their supporters in the legal profession. In turn, patent law has impacted on the life science industries. Compared to the first edition, which told this story for the first time, the present edition focuses more on specific businesses, products and technologies, including Bayer, Pfizer, GlaxoSmithKline, aspirin, penicillin, monoclonal antibodies and polymerase chain reaction. Another difference is that this second edition also looks into the future, addressing new areas such as systems biology, stem cell research, and synthetic biology, which promises to enable scientists to OC inventOCO life forms from scratch.
What people are saying - Write a review
We haven't found any reviews in the usual places.
Seven Tales of a Patent
The Life Sciences Business and the Patent System
Dyes Drugs and Domagk
No Patents on Life
Mr Pharma Goes to Geneva
The Story So Far
Would We Have Got Where We Are Today Without Patents?
The Future of Patents and the Life Science Industries
Other editions - View all
achieved acid active animals antibiotics aspirin Bayer became benefit biological biotechnology blockbuster drugs British cells century cephalosporin chemistry Ciba cimetidine claims commercial companies competition compound compulsory licensing concerned corporations cortisone court dedicated biotechnology firms developing countries discovered discovery drugs dyes dyestuff economic effective Europe European Patent European Patent Convention filed gene Genentech genetic resources German Glaxo hormones Human Genome Ibid important innovation Institute insulin intellectual property rights interest groups invention inventors issue manufacture medicines Merck microorganisms molecular monopoly negotiations Nonetheless oncomouse organisations organisms patent application patent law Patent Law Treaty Patent Office patent protection patent rights patent system penicillin percent pharma pharmaceutical industry proteins regulation regulatory research and development science industries scientific scientists sector sequence strategy streptomycin substances Syntex synthesised synthetic biology therapeutic trade mark TRIPS Agreement United University Wellcome WIPO